Unilabs Sverige and St. Göran’s Hospital are soon adopting Stratipath Breast for breast cancer risk profiling.

Swedish public radio recently reported that Unilabs Sverige and St. Göran’s Hospital are soon adopting Stratipath Breast for breast cancer risk profiling. We’re proud to collaborate and advance precision diagnostics at one of Sweden’s leading breast cancer clinics. Together, we’re making strides towards more accessible, rapid, and precise cancer care.


Listen to the reportage